非心脏手术心血管风险评估指南中系统评价的方法学质量
该研究检索2010至2021年非心脏手术围术期心血管评估相关临床实践指南,分析其纳入的78篇系统评价,用PRISMA和AMSTAR-2评估报告与方法学质量。PRISMA完成度均值76.9%,AMSTAR-2均值58.0%;Cochrane系统评价表现更好但仅10/78篇。
要点
- 指南引用的系统评价方法学与报告质量存在不足,AMSTAR-2均值仅58.0%。
- Cochrane系统评价质量优于非Cochrane,但仅占10/78篇。
核心结论
- 非心脏手术心血管评估指南所纳入的系统评价在方法学和报告质量的关键领域存在缺陷。
- 鉴于这些指南对临床决策和患者照护重要,倡导提升作为推荐证据的系统评价的报告质量。
研究设计与样本
- 用PubMed检索2010至2021年非心脏手术围术期心血管患者相关临床实践指南,分析其所有系统评价和荟萃分析。
- 共纳入3部临床实践指南,内含78篇系统评价。
- 主要目标用PRISMA和AMSTAR-2评估报告与方法学质量;次要目标比较Cochrane与非Cochrane系统评价。
主要发现
- PRISMA完成度范围34.8%至100.0%,均值76.9%。
- AMSTAR-2完成度范围15.6%至96.9%,均值58.0%。
- Cochrane系统评价通常优于非Cochrane研究,但仅占10/78篇。
关键数值与推荐
- PRISMA完成度均值76.9%(范围34.8%至100.0%)。
- AMSTAR-2完成度均值58.0%(范围15.6%至96.9%)。
临床怎么用
- 麻醉科医生引用指南推荐时,应关注其背后系统评价的方法学质量。
- 对AMSTAR-2评「极低」的系统评价所支持的推荐,临床决策需谨慎解读。
局限性
- 仅纳入3部临床实践指南,样本量有限。
- Cochrane系统评价仅10/78篇,组间比较代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac assessment in noncardiac surgery clinical practice guidelines should be supported by the highest-quality evidence such as that offered by systematic reviews. Currently, the methodological and reporting quality of these studies remains unknown. METHODS: We used PubMed to search for all clinical practice guidelines related to perioperative cardiovascular patients undergoing noncardiac surgery from 2010 to 2021. The included clinical practice guidelines were analysed for all systematic reviews and meta-analyses. The primary objective of this study was to determine reporting and methodological quality using the PRISMA (Preferred Reporting Instrument for Systematic Reviews and Meta-Analyses) and AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews-2) instruments. Our secondary objective was to compare systematic reviews conducted by the Cochrane Collaboration with non-Cochrane studies. RESULTS: Three clinical practice guidelines were included in our study. Within these, 78 systematic reviews were included. PRISMA completion ranged from 34.8% to 100.0% with a mean of 76.9%. AMSTAR-2 completion ranged from 15.6% to 96.9% with a mean of 58.0%. Fifty-four systematic reviews underpinned a clinical practice guidelines recommendation, of which 25 were rated 'critically low' by AMSTAR-2 appraisal. Cochrane systematic reviews typically performed better than non-Cochrane studies, but were a minority of the included studies (10/78). CONCLUSION: We found deficiencies in several key areas regarding the methodological and reporting qualities of systematic reviews included in cardiac assessment in noncardiac surgery clinical practice guidelines. As these clinical practice guidelines are instrumental to clinical decision-making and patient care in cardiac assessment in noncardiac surgery, we advocate for improved reporting quality among systematic reviews cited as supportive evidence for these recommendations.
引用
- Jacobsen SM, Douglas A, Smith CA, et al. Methodological quality of systematic reviews comprising clinical practice guidelines for cardiovascular risk assessment and management for noncardiac surgery. Br J Anaesth. 2021. PMID: 34548174. doi:10.1016/j.bja.2021.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。